Milan’s Superstudio Più hosted the latest edition of the Financecommunity Awards 2022. The event was an opportunity to celebrate the excellence of the world of finance, from banks to investment funds, from asset
Search Results for: Devesa Abogados /feed/awards-menutop/40-under-forty-awards/6918-iberian-lawyer-40-under-forty-awards-winners-announced
Blowing out its first ten candles in the Spanish market is Afiens. We are talking about an alternative legal services firm (ALSP) that was founded in 2012 by Lorena Salamanca “with money and savings from her
Fieldfisher has hired Borja Martinez (pictured) as a new partner in the antitrust practice area. Martínez holds a law degree from Comillas University and a master’s degree in European Union law from Carlos
Alter Legal has hired Alicia Alonso and Iñigo Hernáez to strengthen the practice of alternative investments in primary (fund investments), private equity transactions (buyouts, growth, minorities and co-investments) and secondary transactions (GP leds,
Andersen has just announced the hiring of Marlene Nogueira to reinforce the corporate/m&a area and coordinate the data protection department at the Porto office. The new of counsel at Andersen Portugal moves
Ecija has advised Desigual in its advertising campaign “Nathy Peluso – Desigual”. Desigual is a spanish fashion company founded in 1984. On this occasion, the Advertising Jury of Autocontrol has ruled in favour of the firm and
Auren has appointed José Antonio García-Argudo (pictured) as a new partner to strengthen the insolvency and restructuring area of the firm. García-Argudo holds a law degree from ICADE and has more than 30 years
Jesús Mas (pictured) has joined Fraternidad-Muprespa Legal Advice and Services Centre as new director, taking over from Rafael Domenech, who recently retired. Mas holds a law degree from the Complutense University of Madrid and
by irina wakstein “The most productive work is the one that comes out of the hands of a happy man”, said the French doctor and writer Victor Pauchet and, although at first it may sound
Baker McKenzie client Minoryx Therapeutics, a late-stage biotech company focused on the development of treatments for orphan central nervous system disorders (CNS), and the Neuraxpharm Group, a leading European specialty pharmaceutical company focused on CNS
